ASSOCIATION OF ARGININE VASOPRESSIN-SECRETING CELL, STEROID-SECRETING CELL, ADRENAL AND ISLET-CELL ANTIBODIES IN A PATIENT PRESENTING WITH CENTRAL DIABETES-INSIPIDUS, EMPTY SELLA, SUBCLINICAL ADRENOCORTICAL FAILURE AND IMPAIRED GLUCOSE-TOLERANCE

被引:10
作者
DEBELLIS, A
BIZZARRO, A
DIMARTINO, S
SAVASTANO, S
SINISI, AA
LOMBARDI, G
BELLASTELLA, A
机构
[1] UNIV NAPLES 2,FAC MED & CHIRURG,DEPT CLIN PHYSIOPATHOL,I-80131 NAPLES,ITALY
[2] UNIV NAPLES FEDERICO II,FAC MED & SURG,DEPT ENDOCRINOL,NAPLES,ITALY
关键词
CENTRAL DIABETES INSIPIDUS; ARGININE VASOPRESSIN-SECRETING CELL ANTIBODY; ADRENAL ANTIBODIES; EMPTY SELLA;
D O I
10.1159/000184614
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 36-year-old woman with central diabetes insipidus (DI), diagnosed when she was 7, was referred to our Endocrine Unit in January 1993 for further hormonal investigations. Clinical and laboratory findings confirmed the diagnosis of central DI. Cranial computed tomography and magnetic resonance imaging showed only an empty sella. Moreover, we noted impaired glucose tolerance and unusual findings of subclinical adrenocortical failure, i.e. high plasma renin activity with normal aldosterone levels, high ACTH despite normal basal and ACTH-stimulated cortisol levels. Immunological study of the patient's serum showed the presence of arginine vasopressin (AVP)-secreting cell antibodies (Abs), steroid-producing cell Abs, adrenal and islet cell Abs. The following aspects of our case are stressed and discussed: (1) the presence of AVP-secreting cell Abs 29 years after the diagnosis of DI; (2) the association between DI, empty sella and subclinical autoimmune adrenocortical failure with unusual hormonal findings, and (3) impaired glucose tolerance with islet cell antibody positivity.
引用
收藏
页码:142 / 146
页数:5
相关论文
共 36 条
[1]   ADDISONS-DISEASE AND EMPTY SELLA [J].
AMBROSI, B ;
RIVA, E ;
FERRARIO, R ;
FAGLIA, G .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1988, 11 (03) :215-218
[2]   THE NATURAL-HISTORY OF ADRENAL-FUNCTION IN AUTOIMMUNE PATIENTS WITH ADRENAL AUTOANTIBODIES [J].
BETTERLE, C ;
SCALICI, C ;
PRESOTTO, F ;
PEDINI, B ;
MORO, L ;
RIGON, F ;
MANTERO, F .
JOURNAL OF ENDOCRINOLOGY, 1988, 117 (03) :467-475
[3]   ISLET CELL AND INSULIN AUTOANTIBODIES IN ORGAN-SPECIFIC AUTOIMMUNE PATIENTS - THEIR BEHAVIOR AND PREDICTIVE VALUE FOR THE DEVELOPMENT OF TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS - A 10-YEAR FOLLOW-UP-STUDY [J].
BETTERLE, C ;
PRESOTTO, F ;
PEDINI, B ;
MORO, L ;
SLACK, RS ;
ZANETTE, F ;
ZANCHETTA, R .
DIABETOLOGIA, 1987, 30 (05) :292-297
[4]   PREMATURE OVARIAN FAILURE - AUTOIMMUNITY AND NATURAL-HISTORY [J].
BETTERLE, C ;
ROSSI, A ;
DALLAPRIA, S ;
ARTIFONI, A ;
PEDINI, B ;
GAVASSO, S ;
CARETTO, A .
CLINICAL ENDOCRINOLOGY, 1993, 39 (01) :35-43
[5]  
BIGAZZI PE, 1985, AUTOIMMUNITY ENDOCRI, P345
[6]   IMMUNOLOGY AND DIABETES WORKSHOP - REPORT ON THE 3RD INTERNATIONAL (STAGE-3) WORKSHOP ON THE STANDARDIZATION OF CYTOPLASMIC ISLET CELL ANTIBODIES HELD IN NEW-YORK, NEW-YORK, OCTOBER 1987 [J].
BOITARD, C ;
BONIFACIO, E ;
BOTTAZZO, GF ;
GLEICHMANN, H ;
MOLENAAR, J .
DIABETOLOGIA, 1988, 31 (07) :451-452
[7]  
BOSI E, 1991, DIABETES NUTR METAB, V4, P319
[8]   ISLET-CELL ANTIBODIES IN DIABETES-MELLITUS WITH AUTOIMMUNE POLY-ENDOCRINE DEFICIENCIES [J].
BOTTAZZO, GF ;
FLORINCH.A ;
DONIACH, D .
LANCET, 1974, 2 (7892) :1279-1283
[9]   PERSISTENCE OF SERUM ANTIBODIES TO 64,000-MR ISLET CELL PROTEIN AFTER ONSET OF TYPE-I DIABETES [J].
CHRISTIE, MR ;
DANEMAN, D ;
CHAMPAGNE, P ;
DELOVITCH, TL .
DIABETES, 1990, 39 (06) :653-656
[10]  
CLAYTON R, 1977, LANCET, V2, P954